The FDA has granted approval for Ionis Pharmaceuticals’ Dawnzera (donidalorsen), for use in preventing hereditary angioedema (HAE) attacks.

Since 2008, the FDA has approved 11 treatments for a rare genetic condition called hereditary angioedema (HAE), three of which have occurred in the last two months. | Since 2008, the FDA has approved 11 treatments for the rare genetic condition hereditary angioedema (HAE),